Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 19;8(6):e66312.
doi: 10.1371/journal.pone.0066312. Print 2013.

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011

Deliana Kostova  1 , Carrie Reed, Lyn Finelli, Po-Yung Cheng, Paul M Gargiullo, David K Shay, James A Singleton, Martin I Meltzer, Peng-Jun Lu, Joseph S Bresee
Affiliations

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011

Deliana Kostova et al. PLoS One. .

Abstract

Context: The goal of influenza vaccination programs is to reduce influenza-associated disease outcomes. Therefore, estimating the reduced burden of influenza as a result of vaccination over time and by age group would allow for a clear understanding of the value of influenza vaccines in the US, and of areas where improvements could lead to greatest benefits.

Objective: To estimate the direct effect of influenza vaccination in the US in terms of averted number of cases, medically-attended cases, and hospitalizations over six recent influenza seasons.

Design: Using existing surveillance data, we present a method for assessing the impact of influenza vaccination where impact is defined as either the number of averted outcomes or as the prevented disease fraction (the number of cases estimated to have been averted relative to the number of cases that would have occurred in the absence of vaccination).

Results: We estimated that during our 6-year study period, the number of influenza illnesses averted by vaccination ranged from a low of approximately 1.1 million (95% confidence interval (CI) 0.6-1.7 million) during the 2006-2007 season to a high of 5 million (CI 2.9-8.6 million) during the 2010-2011 season while the number of averted hospitalizations ranged from a low of 7,700 (CI 3,700-14,100) in 2009-2010 to a high of 40,400 (CI 20,800-73,000) in 2010-2011. Prevented fractions varied across age groups and over time. The highest prevented fraction in the study period was observed in 2010-2011, reflecting the post-pandemic expansion of vaccination coverage.

Conclusions: Influenza vaccination programs in the US produce a substantial health benefit in terms of averted cases, clinic visits and hospitalizations. Our results underscore the potential for additional disease prevention through increased vaccination coverage, particularly among nonelderly adults, and increased vaccine effectiveness, particularly among the elderly.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Prevented fraction of influenza cases, by age group, 2005/06–2010/11 influenza seasons.
Figure 2
Figure 2. Number of averted influenza cases, by age group, 2005/06–2010/11 influenza seasons.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Advisory Committee on Immunization Practices (ACIP) (2010) Prevention and Control of Influenza with Vaccines. MMWR 59: 1–62. - PubMed
    1. Advisory Committee on Immunization Practices (ACIP) (2009) Prevention and Control of Influenza with Vaccines. MMWR 58: 1–52. - PubMed
    1. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, et al. (2009) Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J Infect Dis 199(2): 159–67. - PubMed
    1. Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, et al. (2008) Prevention of symptomatic seasonal influenza in 2005–2006 by inactivated and live attenuated vaccines. J Infect Dis 198(3): 312–7. - PMC - PubMed
    1. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, et al. (2007) Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25(15): 2842–51. - PubMed

Substances